The von Willebrand factor (vWF) is a plasma glycoprotein that plays an essential role in
hemostasis by supporting platelet adhesion and thrombus formation in response to vascular
injury. Plasma levels of vWF are an independent risk factor for patients with acute
myocardial infarction (AMI); however, clinical data have demonstrated a marked variation of
vWF levels in patients with AMI, the reason for which has not yet been identified. In the
present study, a rat model of ST‑segment elevation AMI was established, and cardiac and …